Prot# H6Q-MC-JCCB: A Phase 2, Open-Label, Multicenter Study of Single-Agent Enzastaurin in Patients with Relapsed Cutaneous T-Cell Lymphoma

    Project: Research project

    Project Details

    StatusFinished
    Effective start/end date8/8/088/8/11

    Funding

    • Eli Lilly and Company (H6Q-MC-JCCB)